Dr. Lindy S. Klaff, MD

Dr. Klaff practices at EvergreenHealth Medical Center Kirkland in Kirkland, Washington.

Dr. Klaff's NPI, 1093891889, was assigned on October 27, 2006. Dr. Klaff graduated from University of Washington School of Medicine in 2002. Dr. Klaff holds Washington license MD00043962.

Dr. Klaff's primary practice is EvergreenHealth Medical Center Kirkland, at 12040 Ne 128th St, Kirkland, WA 98034 in King County. The practice phone is (425) 899-1000.

Dr. Klaff's primary practice is EvergreenHealth Medical Center Kirkland in Kirkland, Washington. Dr. Klaff is also affiliated with EvergreenHealth Medical Center. The medical group on file is Booth Gardner Parkinson's Care Center. Dmand AI also links Dr. Klaff to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klaff practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Klaff's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Klaff is licensed in Washington.

CMS data shows 805 Medicare services from Dr. Klaff across 14 procedure codes in 2024, for 281 Medicare patients. Medicare paid $63,505 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 281 Medicare patients who saw Dr. Klaff in 2024. The largest group is 75 to 84, with 126 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Klaff's median patient age at 75, with 65% women.

In 2024, Dr. Klaff wrote 2,201 Medicare Part D claims for 352 patients. 56% of them were for generic drugs. CMS names the drug for 1,939 of them, across 39 drugs with 11 or more claims each, at $565,237 in total drug cost. In 2023, CMS named 1,771 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Klaff for performance year 2024, reported through an alternative payment model (APM). Dr. Klaff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Klaff as offering telehealth.

Dmand AI links 2 papers to Dr. Klaff in 2012. Dr. Klaff's most frequent co-authors are Sharukh Lokhandwala, MD and Brent E. Wisse, MD.

CMS Open Payments shows 5 general payments to Dr. Klaff from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Covidien Sales LLC paid the most, $93.

Dr. Klaff graduated from University of Washington School of Medicine in 2002.